Literature DB >> 3072140

Clinical pharmacokinetics of doxycycline and minocycline.

S Saivin1, G Houin.   

Abstract

Doxycycline and minocycline are second-generation tetracyclines. They are readily absorbed, distributed throughout the organism as a function of their lipophilicity and eliminated in both the urine and the faeces. The influence of age, renal disease, malnutrition and hyperlipidaemia is reviewed, together with the main pharmacokinetic interactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3072140     DOI: 10.2165/00003088-198815060-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  59 in total

Review 1.  The penetration of antibiotics into cerebrospinal fluid and brain tissue.

Authors:  R W Barling; J B Selkon
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

2.  Absorption of minocycline.

Authors:  C Smith; C G Woods; M J Woods
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

3.  Pharmacokinetics of doxycycline polyphosphate after oral multiple dosing in humans.

Authors:  M C Saux; J Mosser; H Pontagnier; B Leng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

4.  [Use of doxycycline in human renal failure].

Authors:  P Y Zech
Journal:  Nouv Presse Med       Date:  1980-01-10

5.  Pharmacokinetics and plasma steady state levels of doxycycline in undernutrition.

Authors:  T C Raghuram; K Krishnaswamy
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

Review 6.  Minocycline.

Authors:  M Jonas; B A Cunha
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

7.  Effect of alcoholic beverages on the pharmacokinetics of doxycycline in man.

Authors:  M J Mattila; U Laisi; M Linnoila; R Salonen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-05

8.  Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract.

Authors:  A Whelton; L J Blanco; G G Carter; T J Craig; H H Bryant; D V Herbst; T M King
Journal:  Obstet Gynecol       Date:  1980-01       Impact factor: 7.661

9.  Comparative pharmacokinetics of doxycycline and oxytetracycline in patients with hyperlipidemia.

Authors:  J Wójcicki; W Kalinowski; B Gawrońska-Szklarz
Journal:  Arzneimittelforschung       Date:  1985

10.  Clinical evaluation of intravenous minocycline.

Authors:  J H Rogers; P A Barnwell; N G Waterman; F D Austin; M J Raff
Journal:  Int J Clin Pharmacol Biopharm       Date:  1977-04
View more
  91 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  No findings of dental defects in children treated with minocycline.

Authors:  Antonio Cascio; Chiara Di Liberto; Matteo D'Angelo; Chiara Iaria; Francesco Scarlata; Lucina Titone; Giuseppina Campisi
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

3.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 4.  Pharmacokinetics of antimicrobial agents in organ function impairment. A review.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

5.  Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition.

Authors:  Tao Pang; Juan Wang; Julius Benicky; Juan M Saavedra
Journal:  Biochim Biophys Acta       Date:  2012-01-27

6.  In Vitro Susceptibility of Treponema pallidum subsp. pallidum to Doxycycline.

Authors:  Diane G Edmondson; Gary P Wormser; Steven J Norris
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

7.  Tetracycline suppresses ATP gamma S-induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell-1 (HMEC-1) cell line and primary human dermal microvascular endothelial cells.

Authors:  Anna Bender; Tamar Zapolanski; Shannon Watkins; Ava Khosraviani; Kristina Seiffert; Wanhong Ding; John A Wagner; Richard D Granstein
Journal:  Exp Dermatol       Date:  2008-03-13       Impact factor: 3.960

8.  In Vitro Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae.

Authors:  Dennis Huang; Brenda Yu; John K Diep; Rajnikant Sharma; Michael Dudley; Jussimara Monteiro; Keith S Kaye; Jason M Pogue; Cely Saad Abboud; Gauri G Rao
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

9.  Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.

Authors:  E Vieler; C Jantos; H L Schmidts; W Weidner; H G Schiefer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.

Authors:  Xiang Fan; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2013-02-19       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.